두개내압(ICP) 모니터링 시장 : 기술별, 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Intracranial Pressure Monitoring Market By Technique, By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,174,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,342,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

두개내압(ICP) 모니터링 시장

두개내압(ICP) 모니터링 시장은 2023년 4억 달러로 평가되며, 2024년부터 2033년까지 연평균 5.1% 성장하여 2033년에는 6억 달러에 달할 것으로 예상됩니다.

ICP 모니터링은 두개강 내 뇌척수액, 혈액 등 특정 유체가 두개강 내 압력을 측정하는 진단 검사입니다. 카테터나 센서를 뇌의 뇌척수액 공간에 삽입하여 압력을 측정하는 것으로, 뇌졸중, 외상성 뇌손상, 뇌종양, 신경질환 등 다양한 질환에서 ICP 모니터링은 매우 중요한 역할을 합니다. 의료진은 ICP 모니터링을 통해 뇌 손상의 강도를 평가하고 두개 내 동역학 변화를 파악하여 치료법을 결정합니다.

지속적인 기술 발전으로 인해 ICP 모니터링의 효율성이 급증하는 것이 시장 성장의 주요 촉진요인입니다. 무선 연결, 센서의 소형화, 디지털 건강 플랫폼과의 동화는 의료 서비스 제공자가 실시간 데이터를 수집하고 정보에 입각한 의사결정을 내리고 신경이 중요한 환경에서 환자 치료를 개선할 수 있게 해줍니다. 향후 비침습적 ICP 모니터링 트렌드가 의료 현장에서 주류가 될 것으로 예상됩니다. 현재 경두개 도플러 초음파, 뇌조직 공명법, 정맥 안압계 등 기존 비침습적 시술의 한계를 완화하기 위한 연구 개발 노력이 빠르게 진행되고 있습니다.

그러나 첨단 기술의 발전으로 인해 진단 검사의 가격이 높아져 많은 사람들이 감당할 수 없는 수준에 이르렀습니다. 또한, ICP 모니터링 관련 장비의 높은 초기 비용과 교정, 유지보수 및 소모품 비용으로 인해 중소규모의 의료 시설에서는 투자하기가 쉽지 않습니다. 반대로 AI의 도입은 두개내압(ICP) 모니터링 시장에 새로운 길을 열어줄 것으로 기대되는 혁신 분야로, AI는 기기에서 생성되는 대규모 데이터 세트를 분석하여 사람의 관찰로는 놓칠 수 있는 이상 징후를 찾아낼 수 있을 것으로 예상됩니다. 제안은 의료 대응의 적시 전달을 지원하여 환자 결과를 개선할 수 있을 것으로 예상됩니다.

부문 리뷰

두개내압(ICP) 모니터링 시장은 기술, 용도, 최종사용자, 지역으로 구분됩니다. 기술별로는 침습성과 비침습성으로 구분됩니다. 응용 분야는 외상성 뇌손상, 뇌출혈, 수막염, 기타로 나뉩니다. 최종사용자별로는 병원, 클리닉, 민간 의료기관, 외상센터, 정부 및 연구기관으로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

시술별로는 비침습성이 2023년 시장에서 가장 높은 수익을 올린 것으로 나타났습니다.

용도별로는 외상성 뇌손상 부문이 2023년 가장 높은 매출을 기록했습니다.

최종사용자별로는 병원 부문이 2023년 시장에서 더 높은 지분을 차지했습니다.

본 보고서의 커스터마이징 가능성(추가 비용 및 일정이 필요합니다. )

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 개요 확장 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 두개내압(ICP) 모니터링 시장 : 기술별

• 시장 개요
• 침습성
• 비침습성

제5장 두개내압(ICP) 모니터링 시장 : 용도별

• 시장 개요
• 외상성 뇌손상
• 뇌내출혈
• 수막염
• 기타

제6장 두개내압(ICP) 모니터링 시장 : 최종사용자별

• 시장 개요
• 병원
• 진료소
• 개인 의원
• 외상 센터
• 정부기관 및 연구기관

제7장 두개내압(ICP) 모니터링 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 두개내압(ICP) 모니터링 시장
  • 캐나다의 두개내압(ICP) 모니터링 시장
  • 멕시코의 두개내압(ICP) 모니터링 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 두개내압(ICP) 모니터링 시장
  • 독일의 두개내압(ICP) 모니터링 시장
  • 이탈리아의 두개내압(ICP) 모니터링 시장
  • 스페인의 두개내압(ICP) 모니터링 시장
  • 영국의 두개내압(ICP) 모니터링 시장
  • 기타 유럽의 두개내압(ICP) 모니터링 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 두개내압(ICP) 모니터링 시장
  • 일본의 두개내압(ICP) 모니터링 시장
  • 인도 두개내압(ICP) 모니터링 시장
  • 한국의 두개내압(ICP) 모니터링 시장
  • 호주 두개내압(ICP) 모니터링 시장
  • 기타 아시아태평양의 두개내압(ICP) 모니터링 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 두개내압(ICP) 모니터링 시장
  • 남아프리카공화국의 두개내압(ICP) 모니터링 시장
  • 사우디아라비아의 두개내압(ICP) 모니터링 시장
  • 기타 라틴아메리카, 중동 및 아프리카 두개내압(ICP) 모니터링 시장

제8장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• BrainLAB
• Natus Medical Incorporated
• Integra LifeSciences
• GE Healthcare
• Teleflex Incorporated
• Sick AG
• Smiths Medical
• Koninklijke Philips N.V
• Elekta AB
• AMETEK

ksm

영문 목차

영문목차

Intracranial Pressure (ICP) Monitoring Market

The intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

ICP monitoring is a diagnostic test for measuring the pressure inside the skull, exerted by certain fluids such as cerebrospinal fluid and blood within the cranial cavity. A catheter or sensor is inserted into the cerebrospinal fluid space of brain in this procedure to gauge the pressure. Conducting ICP monitoring is pivotal in various medical conditions, including stroke, traumatic brain injury, brain tumors, and neurological disorders. Healthcare providers assess the intensity of brain injury through ICP monitoring, identify modifications in intracranial dynamics, and make treatment decisions.

Surge in the efficacy of ICP monitoring due to continuous technological advancements is a major driver of the market. Wireless connectivity, miniaturization of sensors, and assimilation with digital health platforms have enabled healthcare providers to garner real-time data, make well-informed decisions, and elevate patient care in neurocritical settings. In future, the trend of non-invasive ICP monitoring is projected to dominate in the healthcare settings. Currently, R&D efforts are in full pace to mitigate the limitations of existing non-invasive procedures such as transcranial doppler ultrasonography, brain tissue resonance, and venous ophthalmodynamometry.

However, cutting-edge technological advancements result in high cost of diagnostic tests, making it unaffordable for several individuals. Moreover, the high initial cost of procuring equipment associated with ICP monitoring; along with calibration, maintenance, and consumable expenses; makes it challenging for several small & medium-sized healthcare facilities to invest in them. On the contrary, the deployment of AI is a field of innovation expected to open new avenues for the intracranial pressure (ICP) monitoring market. AI is anticipated to analyze large datasets generated from the equipment and identify the abnormalities that are possible skippable by human observation. Suggestions offered by predictive model of AI are projected to aid in on-time delivery of medical responses, hence improving patient outcomes.

Segment Review

The intracranial pressure (ICP) monitoring market is segmented into technique, application, end user, and region. On the basis of technique, the market is bifurcated into invasive and non-invasive. By application, it is divided into traumatic brain injury, intracerebral hemorrhage, meningitis, and others. Depending on end user, it is classified into hospital, clinics, private medical offices, trauma centers, and government & research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of technique, the non-invasive segment generated the highest revenue in the market in 2023.

By application, the traumatic brain injury segment was the highest revenue generator in 2023

Depending on end user, the hospital segment acquired higher stakes of the market in 2023.

Competition Analysis

The major players operating in the global intracranial pressure (ICP) monitoring market include BrainLAB, Natus Medical Incorporated, Integra LifeSciences, GE Healthcare, Teleflex Incorporated, Sick AG, Smiths Medical, Koninklijke Philips N.V, Elekta AB, and AMETEK. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Technique

• Invasive
• Non-Invasive

By Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Others

By End User

• Hospital
• Clinics
• Private Medical Offices
• Trauma Centers
• Government and Research Organizations

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• BrainLAB
• Natus Medical Incorporated
• Integra LifeSciences
• GE Healthcare
• Teleflex Incorporated
• Sick AG
• Smiths Medical
• Koninklijke Philips N.V
• Elekta AB
• AMETEK

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY TECHNIQUE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Technique
• 4.2. Invasive
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Non-Invasive
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Traumatic Brain Injury
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Intracerebral Hemorrhage
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Meningitis
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospital
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Clinics
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Private Medical offices
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country
• 6.5. Trauma Centers
  • 6.5.1. Key Market Trends, Growth Factors and Opportunities
  • 6.5.2. Market Size and Forecast, By Region
  • 6.5.3. Market Share Analysis, By Country
• 6.6. Government And Research Organizations
  • 6.6.1. Key Market Trends, Growth Factors and Opportunities
  • 6.6.2. Market Size and Forecast, By Region
  • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: INTRACRANIAL PRESSURE (ICP) MONITORING MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Technique
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Intracranial Pressure (ICP) Monitoring Market
    • 7.2.6.1. Market Size and Forecast, By Technique
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Intracranial Pressure (ICP) Monitoring Market
    • 7.2.7.1. Market Size and Forecast, By Technique
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Intracranial Pressure (ICP) Monitoring Market
    • 7.2.8.1. Market Size and Forecast, By Technique
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Technique
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Intracranial Pressure (ICP) Monitoring Market
    • 7.3.6.1. Market Size and Forecast, By Technique
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Intracranial Pressure (ICP) Monitoring Market
    • 7.3.7.1. Market Size and Forecast, By Technique
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Intracranial Pressure (ICP) Monitoring Market
    • 7.3.8.1. Market Size and Forecast, By Technique
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Intracranial Pressure (ICP) Monitoring Market
    • 7.3.9.1. Market Size and Forecast, By Technique
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Intracranial Pressure (ICP) Monitoring Market
    • 7.3.10.1. Market Size and Forecast, By Technique
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Intracranial Pressure (ICP) Monitoring Market
    • 7.3.11.1. Market Size and Forecast, By Technique
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Technique
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Intracranial Pressure (ICP) Monitoring Market
    • 7.4.6.1. Market Size and Forecast, By Technique
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Intracranial Pressure (ICP) Monitoring Market
    • 7.4.7.1. Market Size and Forecast, By Technique
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Intracranial Pressure (ICP) Monitoring Market
    • 7.4.8.1. Market Size and Forecast, By Technique
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Intracranial Pressure (ICP) Monitoring Market
    • 7.4.9.1. Market Size and Forecast, By Technique
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Intracranial Pressure (ICP) Monitoring Market
    • 7.4.10.1. Market Size and Forecast, By Technique
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Intracranial Pressure (ICP) Monitoring Market
    • 7.4.11.1. Market Size and Forecast, By Technique
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Technique
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Intracranial Pressure (ICP) Monitoring Market
    • 7.5.6.1. Market Size and Forecast, By Technique
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Intracranial Pressure (ICP) Monitoring Market
    • 7.5.7.1. Market Size and Forecast, By Technique
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Intracranial Pressure (ICP) Monitoring Market
    • 7.5.8.1. Market Size and Forecast, By Technique
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Intracranial Pressure (ICP) Monitoring Market
    • 7.5.9.1. Market Size and Forecast, By Technique
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. BrainLAB
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Natus Medical Incorporated
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Integra LifeSciences
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. GE Healthcare
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Teleflex Incorporated
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Sick AG
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Smiths Medical
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. Koninklijke Philips N.V
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Elekta AB
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. AMETEK
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료